Early research (Phase 1)Study completedNCT00064090
What this trial is testing
3-AP and Cytarabine in Treating Patients With Hematologic Cancer
Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Vion Pharmaceuticals